Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Gastrointest Surg. 2016 Oct 6;20(12):2002–2009. doi: 10.1007/s11605-016-3285-x

Figure 1.

Figure 1

(A) Overall survival of 508 patients with advanced-stage HCC treated using TACE. (B) Comparison of survival times based on Child-Pugh class, (C) based on Eastern Cooperative Oncology Group (ECOG) performance score, (D) based on presence of Portal vein tumor thrombosis (PVTT), (E) based on presence of extrahepatic metastasis, and (F) based on alpha-fetoprotein level.